Life Science Innovation: Who Should Pay?
Is Business Broken?
Navigating the Funding Landscape for Gene Therapy
This chapter explores the intricate challenges of funding innovative therapies, especially in gene therapy, and emphasizes collaboration among academia, venture capital, and government. It highlights the need for evolving financing models that prioritize value-based agreements to improve access while addressing the high risks of innovation. Additionally, the discussion sheds light on the financial dynamics of health insurance coverage for expensive therapies, and the impact on patients, particularly focusing on underinsurance issues and ethical considerations in healthcare costs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
